Yes, COVID-19 vaccines remain approved and accessible in India, though the landscape looks quite different now compared to the emergency rollout most people remember from the height of the pandemic. What started as a nationwide, urgent vaccination push has settled into a more standard part of India's regulatory and public health system.
Vaccines Currently Approved
The Government of India maintains an official, periodically updated list of approved COVID-19 vaccines, covering options permitted for manufacture, primary vaccination, and booster administration under emergency use provisions.
Vaccine | Status |
|---|---|
Covishield | Approved for restricted emergency use |
Covaxin | Approved for restricted emergency use |
Corbevax | Approved |
Covovax | Approved for restricted emergency use |
Additional vaccines have received approvals for manufacture, sale, or distribution in the country since these original approvals, and the government continues updating this list as new formulations move through regulatory review. This ongoing update process itself signals that COVID-19 vaccination hasn't been shelved as a completed program, it remains part of India's active pharmaceutical and public health oversight.
The CoWIN Platform Is Still Active
CoWIN, India's official government portal for COVID-19 vaccination registration and booking, remains listed as currently active, operated by the Ministry of Health and Family Welfare. The platform displays available vaccination slots in nearby areas, generates digital vaccination certificates, and continues functioning as India's central system for tracking vaccine administration nationwide. Registration through CoWIN uses a mobile number and one-time password, followed by scheduling an appointment at a nearby vaccination center.
How the Program Has Evolved
Government-run vaccination centers have historically provided vaccines free of cost, with private centers charging a fee, a structure that shaped how doses were distributed across income levels and regions
The mass emergency vaccination campaign that defined the early pandemic years has scaled back considerably since the acute crisis phase ended, shifting toward more targeted availability and approval tracking rather than nationwide compulsory drives
Eligibility and booster guidance expanded progressively over time, extending down to younger age groups and adding provisions for frontline workers, healthcare staff, and high-risk populations with comorbidities
Why the Rollout Looks Different Today
During the peak emergency response, India ran one of the largest vaccination programs in the world, built on infrastructure originally repurposed from an earlier immunization tracking platform. That scale of urgency simply isn't the current reality, since the acute public health emergency has passed. What remains is the regulatory backbone, approved vaccines, an active booking platform, and ongoing government oversight, without the same nationwide mobilization that characterized the initial rollout.
What This Means Practically
Vaccines against COVID-19 remain legally approved and available through India's regulatory system, and the infrastructure built during the pandemic, CoWIN registration, digital certificates, government vaccination centers, continues to exist and function. For current, location-specific availability and eligibility, checking cowin.gov.in directly remains the most reliable step, since exact rollout details, access points, and eligibility criteria have shifted meaningfully since the height of the pandemic response.
Sources:
Government of India, official list of approved COVID-19 vaccines (via Medical Dialogues, referencing official government data): https://medicaldialogues.in/news/industry/pharma/govt-releases-updated-list-of-approved-covid-19-vaccines-in-india-for-2026-170322
CoWIN, official Government of India vaccination portal, Ministry of Health and Family Welfare: https://www.cowin.gov.in/